Krishna Institute Of Medical Sciences Limited · NSE:KIMS
Krishna Institute Of Medical Sciences — Q1 FY26 Earnings Presentation
31 slides from Krishna Institute Of Medical Sciences's earnings presentation, Aug 6, 2025
Slide 1: Cover letter to stock exchanges: Investor Presentation
06th August 2025 The General Manager, The Manager, Department of Corporate Services Listing Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No.C/1, 'G' Block, Mumbai - 400 001. Bandra - Ku
Slide 2: Q1 FY26 Update
Q1 FY26 UPDATE Private & Confidential
Slide 3: Driven by a Vision
Driven by a Vision Affordable Quality Care VISION: Best-in-Class Facilities Patient Centric Systems & Processes S To be the most preferred NT TIE healthcare services brand by PA providing affordable care and best clinical outcomes to patients. Clinical Outcome Driven Excellence And to be the best pl
Slide 4: Multi Specialty Care
Multi Specialty Care Brain Eyes Bones and Spine Radiology • Neurology • Ophthalmology • Orthopedics • Imaging • Neurosurgery Gastro Intestinal Tract • Arthroscopic Surgery • Interventional Radiology • Psychiatry • Medical Gastroenterology • Spine Surgery Lab Services • Neuro Rehabilitation • Surgica
Slide 5: KIMS at a Glance
KIMS at a Glance Telangana Secunderabad (1000) Maharashtra Begumpet (290) Nagpur (334) Kondapur (220) + 500 beds under construction Nashik (325) Gachibowli (237) Thane (300) Asian Transcare (60) Sangli (350) MIPPL (10) Karnataka Andhra Pradesh Bengaluru Vizag (KIMS ICON: 434) Soulspace (450) - Under
Slide 6: Dr. B. Bhaskar Rao - Visionary Behind KIMS
Dr. B. Bhaskar Rao - Visionary Behind KIMS Chairman & Managing Director A legend in CT Surgery, Dr. Bollineni Bhaskar Rao {MBBS, MS, DNB (CT Surgery)} is one of the very few Cardio- Thoracic Surgeons in the country, who performed over 30000 surgeries in his career spanning over more than 25 years. W
Slide 7: Dr. Abhinay Bollineni
Dr. Abhinay Bollineni Chief Executive Officer Dr. Abhinay Bollineni joined KIMS Hospitals in 2013 and spent the next couple of years in Hospital Operations before taking charge of Strategy & Marketing for the Group in 2015. He was appointed as the CEO in 2019. Dr. B. Abhinay completed MBBS from the
Slide 8: Board of Directors
Board of Directors Dr. Bhaskara Rao Bollineni Dr. Abhinay Bollineni Mrs. Anitha Dandamudi Mr. Saumen Chakraborty Chairman & Managing Director Chief Executive Officer Whole-time Director Independent Director, Chairman (Audit Committee) Mr. Adwik Bollineni Mr. Venkata Ramudu Jasthi Mrs. Y. Prameela Ra
Slide 9: Shareholding Pattern - As on 30th June, 2025
Shareholding Pattern - As on 30th June, 2025 Retail & Others, Retail Pre IPO, 9.6% 6.9% Promoters, 34.1% Share Holder No of Shares Share Holding % Category Promoter 13,64,89,330 34.1% SBI MF 2,40,75,106 6.0% DII Axis MF 2,09,78,061 5.2% DII FII, 17.1% HDFC MF 1,75,44,343 4.4% DII SBI Insurance 1,37,
Slide 10: Modern Medical Technology
Modern Medical Technology 4-Arm HD da Vinci MrGFUS Focussed Tulsa-Pro System Robotic Surgical Ultrasound A non- invasive procedure that System Revolutionary Knifeless Brain uses real-time MRI guidance Facilitates complex surgeries procedure for treating tremors. to precisely deliver thermal that are
Slide 11: Many Firsts...
Many Firsts... • First in Asia in to do Trans catheter • India’s first COVID Double Lung • Number 1 in Nephrology treatments in Tricuspid Valve replacement transplant done in 2020 Andhra Pradesh* procedure done in 2018 • India’s first Breathing Lung transplant • Number 1 in Neurosurgery & Poly • Lar
Slide 12: Key Accomplishments
Key Accomplishments NAL ACCRED TIO IT NA AT ER ION INT QU Y ET LI AF A TY & PAT I E N T S Pharmacie De Qualite (PDQ) American Accreditation Commission Certification Overall PDQ Evaluation ‘Best Patient Friendly Hospital’ NABH Digital Standards Accreditation Ranked No. 1 Hospital International (AACI)
Slide 13: Consistent Performer over 2 decades
Consistent Performer over 2 decades (Rupees in Millions) 30,670 7,590 25,143 6,200 22,235 5,766 7% 29. .9% GR: R : 26 16,711 CA 5,217 CAG 11,287 2,412 4,280 773 1,311 317 263 42 2005 2010 2015 2020 2022 2023 2024 2025 2005 2010 2015 2020 2022** 2023 2024 2025 No. of No. of No. of No. of No. of No. o
Slide 14: Q1 FY26 Updates
Q1 FY26 Updates 13 Private & Confidential
Slide 15: Financial & Operational Highlights - 1/2
Financial & Operational Highlights - 1/2 (Rupees in Cr) FINANCIAL HIGHLIGHTS Q1 FY26 Consolidated • Total revenue of INR 879 Cr, a growth of 26.8% on YoY and 9.6% on QoQ basis. • EBITDA of INR 200 Cr, a growth of 8.5% on YoY and a de growth of 1.4% on QoQ basis. • EBITDA margin at 22.7% vs. 26.6% in
Slide 16: Financial & Operational Highlights - 2/2
Financial & Operational Highlights - 2/2 OPERATIONAL Q1 FY 26 Consolidated HIGHLIGHTS • ARPOB grew by 11.8% and 3.7% on YoY and QoQ basis respectively • ARPP grew by 9.8% and 2.7% on YoY basis and QoQ basis respectively Consoldiated - FY26 Q1 Results Particulars Q1 FY26 Q4 FY25 Q1 FY25 QoQ YoY IP Vo
Slide 17: Group Operating Performance - 1/2
Group Operating Performance - 1/2 IP VOLUME (‘000) OP VOLUME (‘000) 6.2% 7.2% 11.6% 14.1% 213 57 1,834 502 54 421 469 50 191 1,608 FY24 FY25 Q1 FY25 Q4 FY25 Q1 FY26 FY24 FY25 Q1 FY25 Q4 FY25 Q1 FY26 OCCUPANCY* ARPOB (‘000) (11.3%) 0.8% 22.7% 3.7% 61.3% 56.5% 39.2 43.0 48.8% 41.5 48.0% 31.9 38.5 50.1
Slide 18: Group Operating Performance - 2/2
Group Operating Performance - 2/2 Particulars FY24 FY25 Q1 FY25 Q4 FY25 Q1 FY26 Bed Capacity# 3,975 5,179 3,975 5,179 5,499 Operational Beds 3,503 4,492 3,503 4,492 4,612 Census Beds 2,989 3,924 2,989 3,924 4,044 Non Census Beds 514 603 514 603 603 Occupied Beds 2,148 2,248 1,979 2,157 2,252 Occupan
Slide 19: Group Financial Performance
Group Financial Performance (Rupees in Millions) TOTAL REVENUE EBITDA** (1.4%) 9.6% 22.0% 24.7% 30,670 8,787 8,148 2,025 8,014 1,997 25,143 6,930 6,533 1,840 FY24 FY25 Q1 FY25 Q4 FY25 Q1 FY26 FY24 FY25 Q1 FY25 Q4 FY25 Q1 FY26 PBT* (15.1%) PAT* (19.9%) 21.5% 23.5% 5,581 1,340 4,148 1,061 4,595 1,137
Slide 20: Operational and Financial Performance - 1/2
Operational and Financial Performance - 1/2 Telangana Andhra Pradesh Particulars FY24 FY25 Q1 FY25 Q4 FY25 Q1 FY26 FY24 FY25 Q1 FY25 Q4 FY25 Q1 FY26 Bed Capacity 1727 1797 1727 1797 1817 1914 2214 1914 2214 2214 Operational Beds 1612 1682 1612 1682 1702 1641 1806 1641 1806 1806 Census Beds 1324 1394
Slide 21: Operational and Financial Performance - 2/2
Operational and Financial Performance - 2/2 Maharashtra Kerala Group Particulars FY24 FY25 Q1 FY25 Q4 FY25 Q1 FY26 FY25 Q4 FY25 Q1 FY26 FY24 FY25 Q1 FY25 Q4 FY25 Q1 FY26 Bed Capacity 334 659 334 659 959 509 509 509 3975 5179 3975 5179 5499 Operational Beds 250 630 250 630 730 374 374 374 3503 4492 3
Slide 22: Speciality Mix
Speciality Mix Others Cardiac Sciences 22% 16% Renal Sciences 9% Mother & Child 9% Group Q1 FY26 Organ Oncology Transplant 6% 2% Gastric Sciences 10% Neuro Sciences 11% Orthopaedics 15% 21 Private & Confidential
Slide 23: Payor & Cluster Profile
Payor & Cluster Profile PAYOR MIX CLUSTER TOTAL REVENUE Maharashtra Kerala 4% 9% Aarogyasri Andhra Pradesh 5% 26% Cash Telangana Corporate Group 61% 13% 52% Q1 FY26 Group Q1 FY26 CLUSTER EBITDA Maharashtra Kerala (1%) Insurance (3%) 30% Andhra Pradesh 25% Telangana Group 79% Q1 FY26 1) Telangana - S
Slide 24: Key Achievements in Q1 FY26
Key Achievements in Q1 FY26 23 Private & Confidential
Slide 25: Key Achievements in Q1 FY26
Key Achievements in Q1 FY26 24 Private & Confidential
Slide 26: Key to our success
Key to our success Doctor Affordable Partnerships Quality Care Modern Medical Infra 25 Private & Confidential
Slide 27: Expansion plans
Expansion plans Current Incremental Approx. Revised Expected Units New Departments Beds Beds Capex Year of Operation Bangalore (Project-1) - 450 All Specialities 350-400 Cr Q2 FY26 Bangalore (Project-2) - 350 All Specialities 180-200 Cr Q2 FY26 Ongole 350 50 Cancer Centre 40-50 Cr Q2 FY26 Anantapur
Slide 28: KIMS Hospitals, Thane
KIMS Hospitals, Thane About Thane: Thane’s central location, adequate public transport and multi-lane roads have undoubtedly made it a viable choice for both, home and office buyers. Thane enjoys superb connectivity to Navi Mumbai as well as to the Eastern and Western Suburbs of Mumbai via Ghodbunde
Slide 29: Profit and Loss Statement
Profit and Loss Statement (Rupees in Millions) Consolidated Particulars Q1 FY26 Q4 FY25 Q1 FY25 QoQ(%) YoY(%) FY25 FY24 YoY(%) Operating Revenue 8,716 7,969 6,884 9.4% 26.6% 30,351 24,982 21.5% Other Income 71 45 46 57.8% 54.3% 319 161 98.1% Total Revenue 8,787 8,014 6,930 9.6% 26.8% 30,670 25,143 2
Slide 30: Corporate Structure (As on 30 June'25)
Corporate Structure (As on 30 June'25) th Krishna Institute of Medical Sciences Limited KIMS Secunderabad KIMS Nellore KIMS Rajahmundry KIMS Ongole KIMS Hospitals KIMS QNRI KIMS Swastha (100%) (100%) (100%) (100%) Thane Visakhapatnam Kerala (100%) (100%) (100%) Doctor Partnership Hospitals AHPL KHEP
Slide 31: Thank You
Thank You 30 Private & Confidential
Krishna Institute of Medical Sciences — Q1 FY26 Earnings Presentation on 6ix